Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

114 ARTÍCULOS , VIENDO DEL 46 AL 60

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease

Lebrec J, Ascher-Svanum H, Chen YF, Reed C, Kahle-Wrobleski K, Hake AM, Raskin J, Naderali E, Schuster D, Heine RJ, Kendall DM.

BMC Geriatr. 2016 May 3;16:93. doi: 10.1186/s12877-016-0264-8.

[No longer an individual fate]

Hoffmann R.

Pflege Z. 2016 Mar;69(3):129.

Racial and Ethnic Differences in the Delivery of the Resources for Enhancing Alzheimer's Caregiver Health II Intervention

Graham-Phillips A, Roth DL, Huang J, Dilworth-Anderson P, Gitlin LN.

J Am Geriatr Soc. 2016 Aug;64(8):1662-7. doi: 10.1111/jgs.14204. Epub 2016 Jun 13.

Comparison of neuropsychological and functional outcomes in Alzheimer's disease patients with good or bad response to a cognitive stimulation treatment: a retrospective analysis

Martínez-Moreno M, Cerulla N, Chico G, Quintana M, Garolera M.

Int Psychogeriatr. 2016 Nov;28(11):1821-1833. doi: 10.1017/S104161021600123X. Epub 2016 Aug 9.

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM.

Alzheimers Res Ther. 2016 Nov 15;8(1):47. doi: 10.1186/s13195-016-0214-x.

Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register

Knapp M, Chua KC, Broadbent M, Chang CK, Fernandez JL, Milea D, Romeo R, Lovestone S, Spencer M, Thompson G, Stewart R, Hayes RD.

BMJ Open. 2016 Nov 18;6(11):e013591. doi: 10.1136/bmjopen-2016-013591.

Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW.

BMC Geriatr. 2016 Nov 25;16(1):195. doi: 10.1186/s12877-016-0371-6.

The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective

Salehi A, Ashford JW, Mufson EJ.

Curr Alzheimer Res. 2016;13(1):2-6. doi: 10.2174/1567205012999151021102914.

Atorvastatin May Correct Dyslipidemia in Adult Patients at Risk for Alzheimer's Disease Through an Anti-Inflammatory Pathway

Zhao L, Zhao Q, Zhou Y, Zhao Y, Wan Q.

CNS Neurol Disord Drug Targets. 2016;15(1):80-5. doi: 10.2174/1871527315999160111160143.

Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis

Kansal K, Mareddy M, Sloane KL, Minc AA, Rabins PV, McGready JB, Onyike CU.

Dement Geriatr Cogn Disord. 2016;41(1-2):109-22. doi: 10.1159/000443205. Epub 2016 Feb 9.

Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up

Turró-Garriga O, Garre-Olmo J, Calvó-Perxas L, Reñé-Ramírez R, Gascón-Bayarri J, Conde-Sala JL.

J Alzheimers Dis. 2016;51(2):357-66. doi: 10.3233/JAD-150706.

The Effects of Cognitive Training for Elderly: Results from My Mind Project

Giuli C, Papa R, Lattanzio F, Postacchini D.

Rejuvenation Res. 2016 Dec;19(6):485-494. doi: 10.1089/rej.2015.1791. Epub 2016 Apr 8.

Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers

Schütt T, Helboe L, Pedersen LØ, Waldemar G, Berendt M, Pedersen JT.

J Alzheimers Dis. 2016 Mar 15;52(2):433-49. doi: 10.3233/JAD-151085.

Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhai Y, Yin S, Zhang D.

J Alzheimers Dis. 2016 Mar 31;52(2):631-9. doi: 10.3233/JAD-151207.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias